VKH
BSPM

Virtu KCG Holdings’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Virtu KCG Holdings’s Portfolio BSPM Stock Details BSPM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-17,163
Closed -$64K – 4149
2016
Q3 		$64K Buy
+17,163
New +$62.6K ﹤0.01% 2744
2016
Q1 		– Sell
-2,707
Closed -$8K – 4175
2015
Q4 		$8K Buy
+2,707
New +$11.7K ﹤0.01% 3386
2015
Q3 		– Sell
-1,770
Closed -$13K – 4193
2015
Q2 		$13K Buy
1,770
+177
+11% +$1.58K ﹤0.01% 3220
2015
Q1 		$14K Buy
+1,593
New +$12.8K ﹤0.01% 2994
2014
Q3 		– Sell
-1,568
Closed -$16K – 4432
2014
Q2 		$16K Buy
1,568
+32
+2% +$353 ﹤0.01% 3544
2014
Q1 		$22K Sell
1,536
-1,641
-52% -$26K ﹤0.01% 3423
2013
Q4 		$46K Buy
+3,177
New +$34.3K ﹤0.01% 3617

Other funds holding BSPM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Virtu KCG Holdings's BSPM Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q4 2016, closing a stake of 17,163 shares — an estimated $64K sold.

Virtu KCG Holdings first reported a position in BSPM in Q4 2013 and held it in 7 quarters. The position peaked at $64K in Q3 2016. 7 funds tracked by Wall St. Rank hold BSPM as of Q4 2016.

  • Virtu KCG Holdings reported no remaining Biostar Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 17,163 Biostar Pharmaceuticals, Inc. shares in Q4 2016, an estimated $64K.
  • Virtu KCG Holdings first reported a position in Biostar Pharmaceuticals, Inc. in Q4 2013 and held it in 7 quarters.
  • Virtu KCG Holdings's Biostar Pharmaceuticals, Inc. position peaked at $64K in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.